NRX Total Assets from 2010 to 2025

NRXP Stock  USD 2.08  0.01  0.48%   
NRX Pharmaceuticals Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to drop to about 3.5 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2017-09-30
Previous Quarter
4.5 M
Current Value
3.7 M
Quarterly Volatility
25.2 M
 
Covid
Check NRX Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRX Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 41.8 K, Interest Expense of 218.5 K or Selling General Administrative of 19.6 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRX financial statements analysis is a perfect complement when working with NRX Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRX Pharmaceuticals Correlation against competitors.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

Latest NRX Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of NRX Pharmaceuticals over the last few years. Total assets refers to the total amount of NRX Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in NRX Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. NRX Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRX Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.65 M10 Years Trend
Slightly volatile
   Total Assets   
       Timeline  

NRX Total Assets Regression Statistics

Arithmetic Mean45,957,366
Geometric Mean29,247,491
Coefficient Of Variation63.53
Mean Deviation26,713,302
Median69,565,819
Standard Deviation29,198,182
Sample Variance852.5T
Range67.9M
R-Value(0.87)
Mean Square Error221.7T
R-Squared0.76
Significance0.000012
Slope(5,336,890)
Total Sum of Squares12788T

NRX Total Assets History

20253.5 M
20243.7 M
20237.3 M
202225.8 M
202132.7 M
20202.9 M
201932.1 M

Other Fundumenentals of NRX Pharmaceuticals

NRX Pharmaceuticals Total Assets component correlations

0.99-0.040.86-0.90.970.92-0.87-0.360.97-0.9-0.090.75-0.59-0.50.0-0.56-0.750.53
0.99-0.030.83-0.890.950.92-0.93-0.330.95-0.860.020.7-0.54-0.460.03-0.52-0.710.51
-0.04-0.030.1-0.170.210.26-0.01-0.860.210.04-0.330.26-0.580.01-0.37-0.650.27-0.33
0.860.830.1-0.90.90.91-0.67-0.540.89-0.91-0.480.97-0.82-0.65-0.06-0.79-0.910.6
-0.9-0.89-0.17-0.9-0.92-0.960.80.52-0.920.940.27-0.840.730.560.20.710.71-0.37
0.970.950.210.9-0.920.97-0.82-0.581.0-0.88-0.230.83-0.76-0.55-0.12-0.74-0.710.45
0.920.920.260.91-0.960.97-0.86-0.630.96-0.9-0.220.84-0.79-0.58-0.18-0.77-0.70.35
-0.87-0.93-0.01-0.670.8-0.82-0.860.28-0.820.73-0.29-0.50.40.34-0.010.380.5-0.31
-0.36-0.33-0.86-0.540.52-0.58-0.630.28-0.580.370.52-0.670.910.430.450.930.230.07
0.970.950.210.89-0.921.00.96-0.82-0.58-0.88-0.220.83-0.76-0.55-0.13-0.74-0.710.44
-0.9-0.860.04-0.910.94-0.88-0.90.730.37-0.880.32-0.830.660.60.090.620.82-0.44
-0.090.02-0.33-0.480.27-0.23-0.22-0.290.52-0.220.32-0.670.660.350.120.670.47-0.31
0.750.70.260.97-0.840.830.84-0.5-0.670.83-0.83-0.67-0.91-0.66-0.15-0.9-0.850.53
-0.59-0.54-0.58-0.820.73-0.76-0.790.40.91-0.760.660.66-0.910.670.410.990.6-0.21
-0.5-0.460.01-0.650.56-0.55-0.580.340.43-0.550.60.35-0.660.670.670.590.66-0.01
0.00.03-0.37-0.060.2-0.12-0.18-0.010.45-0.130.090.12-0.150.410.670.37-0.080.65
-0.56-0.52-0.65-0.790.71-0.74-0.770.380.93-0.740.620.67-0.90.990.590.370.55-0.2
-0.75-0.710.27-0.910.71-0.71-0.70.50.23-0.710.820.47-0.850.60.66-0.080.55-0.72
0.530.51-0.330.6-0.370.450.35-0.310.070.44-0.44-0.310.53-0.21-0.010.65-0.2-0.72
Click cells to compare fundamentals

About NRX Pharmaceuticals Financial Statements

NRX Pharmaceuticals shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although NRX Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in NRX Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on NRX Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Assets3.7 M3.5 M

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.